Current and Long-Term Liabilities (Tables)

12 Months Ended

Dec. 31, 2012

Current and Long-Term Liabilities

Schedule of accrued expenses

Accrued expenses consisted of the following as of December 31, 2012 and 2011 (in thousands):

	December 31,
	2012		2011
Clinical, manufacturing and regulatory consulting fees and expenses	$	7,737	$	11,468
Salaries, bonuses, and other compensation		5,236		5,924
Commercial rebates, fees and returns		3,448		5,943
Professional, license, and other fees and expenses		1,719		1,966
Restructuring expense		1,383		2,366
Commercial consulting fees and expenses		815		1,249
Total accrued expenses	$	20,338	$	28,916

Schedule of deferred revenues

Deferred revenues consisted of the following as of December 31, 2012 and 2011 (in thousands):

	December 31,
	2012		2011
Short-term deferred revenues:
Takeda	$	8,854	$	6,096
Other short-term deferred revenues		250		250
Total	$	9,104	$	6,346
Long-term deferred revenues:
Takeda	$	49,350	$	44,196
3SBio		1,000		1,000
Total	$	50,350	$	45,196